OSLO PHARMA INVEST AS

1185 OSLO

Finances

Return on Equity

54,25 %

Current Ratio

1,16

Debt-to-Equity Ratio

1,73

Key figures (NOK)	2022	2021	2020	2019
Revenue	5 064 000	4 543 000	3 096 000	1 317 000
Net Income	23 652 000	1 117 000	167 000	489 000
Total Assets	143 832 000	116 233 000	107 169 000	66 905 000
Total Equity	43 596 000	19 943 000	18 826 000	18 659 000

Income (NOK)	2022	2021	2020	2019
Revenue	5 064 000	4 543 000	3 096 000	1 317 000
Expenditure	820 000	991 000	1 062 000	721 000
Operating Profit	4 244 000	3 553 000	2 034 000	595 000
Financial Income	22 855 000	23 000	15 000	811 000
Financial Costs	3 216 000	2 144 000	1 835 000	779 000
Financial Balance	19 639 000	−2 121 000	−1 820 000	32 000
Earnings Before Tax	23 882 000	1 432 000	214 000	627 000
Tax	230 000	315 000	47 000	138 000
Net Income	23 652 000	1 117 000	167 000	489 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	115 201 000	115 205 000	104 310 000	62 154 000
Total Current Assets	28 632 000	1 028 000	2 859 000	4 751 000
Total Assets	143 832 000	116 233 000	107 169 000	66 905 000
Total Retained Equity	43 446 000	19 793 000	18 676 000	18 509 000
Total Equity	43 596 000	19 943 000	18 826 000	18 659 000
Total Long-Term Debt	75 498 000	75 449 000	71 779 000	40 798 000
Total Current Debt	24 739 000	20 841 000	16 563 000	7 448 000
Total Equity and Debt	143 832 000	116 233 000	107 169 000	66 905 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	5 064 000	4 543 000	3 096 000	1 317 000
Revenue	5 064 000	4 543 000	3 096 000	1 317 000
Cost of Goods Sold	0	0	0	0
Salary Costs	0	0	0	0
Depreciation	4 000	4 000	4 000	4 000
Impairment	0	0	0	0
Expenditure	820 000	991 000	1 062 000	721 000
Operating Profit	4 244 000	3 553 000	2 034 000	595 000
Financial Income	22 855 000	23 000	15 000	811 000
Financial Costs	3 216 000	2 144 000	1 835 000	779 000
Financial Balance	19 639 000	−2 121 000	−1 820 000	32 000
Dividends	0	0	0	0
Net Income	23 652 000	1 117 000	167 000	489 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	114 290 000	114 290 000	103 391 000	61 391 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	3 000	7 000	11 000	15 000
Total Tangible Assets	114 293 000	114 297 000	103 402 000	61 406 000
Total Fiancial Fixed Assets	908 000	908 000	908 000	748 000
Total Fixed Assets	115 201 000	115 205 000	104 310 000	62 154 000
Stock	0	0	0	0
Total Investments	300 000	300 000	300 000	300 000
Cash, Bank	5 262 000	675 000	805 000	563 000
Total Current Assets	28 632 000	1 028 000	2 859 000	4 751 000
Total Assets	143 832 000	116 233 000	107 169 000	66 905 000
Total Equity	43 596 000	19 943 000	18 826 000	18 659 000
Short-Term Group Debt	0	20 082 000	15 852 000	7 113 000
Total Long-Term Debt	75 498 000	75 449 000	71 779 000	40 798 000
Creditors	60 000	8 000	69 000	9 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	24 376 000	531 000	643 000	296 000
Total Current Debt	24 739 000	20 841 000	16 563 000	7 448 000
Total Equity and Debt	143 832 000	116 233 000	107 169 000	66 905 000

Financial indicators	2022	2021	2020	2019
Return on Equity	54,25 %	5,6 %	0,89 %	2,62 %
Debt-to-Equity Ratio	1,73	3,78	3,81	2,19
Operating Profit Margin	83,81 %	78,21 %	65,7 %	45,18 %
Current Ratio	1,16	0,05	0,17	0,64
Quick Ratio	1,16	0,05	0,17	0,64
Equity Ratio	0,3	0,17	0,18	0,28
Gross Profit Margin	100 %	100 %	100 %	100 %